Mr. Travis Cordie is Associate Director for GMP Manufacturing at Kenai Therapeutics. With a background in pluripotent stem cells, genome engineering and GMP manufacturing of cellular therapies, he looks forward to advancing iPSC-derived neuron replacement therapies! He was recently Senior Manufacturing Manager at Clade Therapeutics leading both internal and external GMP manufacturing teams for iPSC cell line derivation, genome engineering and differentiation of iPSCs to T cells. Previously, he was a GMP Operations Manager in the Cell and Gene Therapy Division at R&D Systems, a Biotechne brand, serving as team lead for custom gene editing and banking projects for both research and phase 1 clinical studies.

Mr. Cordie holds a Bachelor of Science in biotechnology from University of Wisconsin-River Falls, and a Master of Science in biomedical engineering from University of Wisconsin-Madison.